Wednesday - January 21, 2026
GSK Enters Agreement to Acquire RAPT Therapeutics
January 21, 2026
LONDON, England, Jan. 21 -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release on Jan. 20, 2026:

* * *

GSK enters agreement to acquire RAPT Therapeutics

* Acquisition includes ozureprubart, a potentially best-in-class anti-IgE antibody, in development for prophylactic protection against food allergens

* Ozureprubart offers potential to protect against food allergy reactions with less frequent dosing c . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products